AAAAAA
Results:
1-8
|
Results: 8
Authors:
Eckert, GP
Kirsch, C
Mueller, WE
Citation: Gp. Eckert et al., Differential effects of lovastatin treatment on brain cholesterol levels in normal and ApoE-deficient mice, NEUROREPORT, 12(5), 2001, pp. 883-887
Authors:
Eckert, GP
Wood, WG
Muller, WE
Citation: Gp. Eckert et al., Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes, J NEURAL TR, 108(8-9), 2001, pp. 1051-1064
Authors:
Muller, WE
Kirsch, C
Eckert, GP
Citation: We. Muller et al., Membrane-disordering effects of beta-amyloid peptides, BIOCH SOC T, 29, 2001, pp. 617-623
Authors:
Eckert, GP
Muller, WE
Citation: Gp. Eckert et We. Muller, Effects of hyperforin on the fluidity of brain membranes, PHARMACOPS, 34, 2001, pp. S22-S25
Authors:
Serdarevic, N
Eckert, GP
Muller, WE
Citation: N. Serdarevic et al., The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse, PHARMACOPS, 34, 2001, pp. S134-S136
Authors:
Eckert, GP
Cairns, NJ
Maras, A
Gattaz, WF
Muller, WE
Citation: Gp. Eckert et al., Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: Specific changes in Alzheimer's disease, DEMENT G C, 11(4), 2000, pp. 181-186
Authors:
Eckert, GP
Cairns, NJ
Muller, WE
Citation: Gp. Eckert et al., Piracetam reverses hippocampal membrane alterations in Alzheimer's disease- Short communication, J NEURAL TR, 106(7-8), 1999, pp. 757-761
Authors:
Muller, WE
Eckert, GP
Eckert, A
Citation: We. Muller et al., Piracetam: Novelty in a unique mode of action, PHARMACOPS, 32, 1999, pp. 2-9
Risultati:
1-8
|